DK562285D0 - Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelser - Google Patents

Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelser

Info

Publication number
DK562285D0
DK562285D0 DK562285A DK562285A DK562285D0 DK 562285 D0 DK562285 D0 DK 562285D0 DK 562285 A DK562285 A DK 562285A DK 562285 A DK562285 A DK 562285A DK 562285 D0 DK562285 D0 DK 562285D0
Authority
DK
Denmark
Prior art keywords
cells
new
tumour
subunit
patient
Prior art date
Application number
DK562285A
Other languages
English (en)
Other versions
DK170781B1 (da
DK562285A (da
Inventor
Janet H Ransom
Richard P Mccabe
Martin V Haspel
Nicholas Pomato
Original Assignee
Litton Bionetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc
Publication of DK562285D0 publication Critical patent/DK562285D0/da
Publication of DK562285A publication Critical patent/DK562285A/da
Application granted granted Critical
Publication of DK170781B1 publication Critical patent/DK170781B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK562285A 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin DK170781B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60030384A 1984-04-13 1984-04-13
US60030384 1984-04-13
US8500626 1985-04-11
PCT/US1985/000626 WO1985004662A1 (en) 1984-04-13 1985-04-11 Leukoregulin, an antitumor lymphokine, and its therapeutic uses

Publications (3)

Publication Number Publication Date
DK562285D0 true DK562285D0 (da) 1985-12-04
DK562285A DK562285A (da) 1985-12-04
DK170781B1 DK170781B1 (da) 1996-01-15

Family

ID=24403068

Family Applications (2)

Application Number Title Priority Date Filing Date
DK562285A DK170781B1 (da) 1984-04-13 1985-12-04 Human leukoregulin og biologisk aktive underenheder deraf, fremgangsmåde til fremstilling og til oprensning af human leukoregulin, biologisk aktivt materiale indeholdende human leukoregulin samt celle, som producerer human leukoregulin
DK098692A DK170423B1 (da) 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK098692A DK170423B1 (da) 1984-04-13 1992-08-04 Monoklonalt antistof, der er specifikt for leukoregulincelleoverfladereceptorer, og fremgangsmåde til fremstilling deraf, hybridoma, som producerer det monoklonale antistof, og prøve for tumorcellefølsomhed under anvendelse af det monoklonale antistof

Country Status (9)

Country Link
EP (1) EP0179127B1 (da)
JP (2) JP2562014B2 (da)
AT (1) ATE48617T1 (da)
AU (2) AU592529B2 (da)
DE (1) DE3574710D1 (da)
DK (2) DK170781B1 (da)
FI (1) FI85867C (da)
NO (1) NO170423C (da)
WO (1) WO1985004662A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592529B2 (en) * 1984-04-13 1990-01-18 Litton Bionetics, Inc. Leukoregulin, an antitumor lymphokine, and its therapeutic uses
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
US6087166A (en) 1997-07-03 2000-07-11 Basf Aktiengesellschaft Transcriptional activators with graded transactivation potential
US20080118979A1 (en) 2006-05-15 2008-05-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
ES2931180T3 (es) 2011-05-19 2022-12-27 Fund Publica Andaluza Progreso Y Salud Sistema de tipo Tet-on lentivírico de promotor dual muy inducible

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394448A (en) * 1978-02-24 1983-07-19 Szoka Jr Francis C Method of inserting DNA into living cells
US4403035A (en) * 1981-06-19 1983-09-06 Regents Of The University Of Minnesota In vitro DNA-Protein viral assembly and gene cloning system
DE3138230A1 (de) * 1981-09-25 1983-04-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von makrophagen- aktivierungsfaktor (maf)
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
US4464465A (en) * 1982-04-05 1984-08-07 Genetic Systems Corporation Cell-driven viral transfer in eukaryotes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
EP0135797A3 (de) * 1983-08-30 1987-11-11 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung von Lymphotoxin und von Lymphotoxin-mRNA
AU592529B2 (en) * 1984-04-13 1990-01-18 Litton Bionetics, Inc. Leukoregulin, an antitumor lymphokine, and its therapeutic uses

Also Published As

Publication number Publication date
DK170781B1 (da) 1996-01-15
JPH06253832A (ja) 1994-09-13
AU592529B2 (en) 1990-01-18
DE3574710D1 (de) 1990-01-18
DK562285A (da) 1985-12-04
DK98692D0 (da) 1992-08-04
DK98692A (da) 1992-08-04
DK170423B1 (da) 1995-08-28
EP0179127A4 (en) 1986-08-21
JPS61501853A (ja) 1986-08-28
EP0179127B1 (en) 1989-12-13
FI854803A (fi) 1985-12-04
AU4234185A (en) 1985-11-01
WO1985004662A1 (en) 1985-10-24
FI85867B (fi) 1992-02-28
NO854994L (no) 1985-12-12
NO170423C (no) 1992-10-14
JP2562014B2 (ja) 1996-12-11
FI85867C (fi) 1992-06-10
EP0179127A1 (en) 1986-04-30
FI854803A0 (fi) 1985-12-04
JP2564245B2 (ja) 1996-12-18
ATE48617T1 (de) 1989-12-15
NO170423B (no) 1992-07-06
AU5365390A (en) 1990-09-20
AU641386B2 (en) 1993-09-23

Similar Documents

Publication Publication Date Title
DK0702563T3 (da) Sammensætninger og fremgangsmåder til behandling af cancer og hyperproliferative sygdomme
CA2202028A1 (en) Tie-2 ligands, methods of making and uses thereof
DE3268915D1 (en) Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
DK562285D0 (da) Leukoregulin, en antitumorlymfokin, og dens terapeutiske anvendelser
DE69332353T2 (de) Verwendung von inhibitoren der synthese von fettsäuren zur behandlung von krebs
US6796937B1 (en) Unipolar biomagnetic therapy appliance
Tagliaferri et al. Two classes of cAMP analogs synergistically inhibit p21 ras protein synthesis and phenotypic transformation of NIH3T3 cells transfected with Ha-MuSV DNA
Backus et al. Tumor-associated bacteria capable of producing a human choriogonadotropin-like substance
CN101875699A (zh) 人表皮生长因子和金属硫蛋白的融合蛋白及其制备方法和应用
CN108884138A (zh) 去免疫的治疗性组合物和方法
CN113956344A (zh) 一种新型治疗肝癌的fgf类似物及其应用
IL99940A0 (en) Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same
AU2001220255A1 (en) Human cervical cancer suppressor protein, polynucleotide encoding the protein, cell transformed with the polynucleotide and method for suppressing proliferationof cancer cell using the expression vector
Miletić et al. The effect of X-irradiation on the degradation of DNA in closely-related strains of E. coli
Agrez et al. A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1
CN101613410A (zh) 核糖核酸酶与毒蛋白膜转位结构域融合蛋白及其制备方法和用途
CN110527680A (zh) 一种透明质酸裂解酶及其基因与应用
CN111793116B (zh) 一种透皮七肽、含有该透皮七肽的美容组合物及制备方法
Matsumoto et al. Stimulation of bone collagenase synthesis by mouse fibrosarcoma in resorbing bone in vitro culture
CN100425699C (zh) scFvC6.5-TNF-α融合基因和蛋白及制备
JPH03505575A (ja) 幹細胞阻害剤
Greenberger et al. Biochemical Purification of a CSF-1 like Molecule Released during Malignant Transformation of IL-3 Dependent Hematopoietic Progenitor cell lines Cocultivated with Gamma Irradiated Clonal Marrow Stromal cell lines
LINES et al. Department Of Radiation Oncology, University Of Massachusetts Medical Center, Worcester, MA 01655 Cocultivation of IL-3 dependent hematopoietic progenitor cell line FDC-P1JL26 with 5000 cGy irradiated clonal bone marrow
RU2039823C1 (ru) Способ получения рекомбинантного лимфотоксина человека
CN116715734A (zh) 一种环状多肽及其在制备抗肿瘤药物中的应用